← FDA Drug Approvals (Drugs@FDA)

ELTROMBOPAG OLAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2024-04-18

Drug application

FDA Application #

ANDA216620

Application type

Abbreviated New Drug Application (Generic)

Brand name

ELTROMBOPAG OLAMINE

Generic name

ELTROMBOPAG OLAMINE

Active ingredients

ELTROMBOPAG OLAMINE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ANNORA PHARMA

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2024-04-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown